FullText URL fulltext.pdf
Author Ushio, Soichiro| Wada, Yudai| Nakamura, Mizuki| Matsumoto, Daiki| Hoshika, Kota| Shiromizu, Shoya| Iwata, Naohiro| Esumi, Satoru| Kajizono, Makoto| Kitamura, Yoshihisa| Sendo, Toshiaki|
Keywords anxiolytic inflammation immunomodulation macrophages Kampo medicine
Published Date 2022-08-12
Publication Title Frontiers In Pharmacology
Volume volume13
Publisher Frontiers Media S.A.
Start Page 890048
ISSN 1663-9812
Content Type Journal Article
language English
OAI-PMH Set 岡山大学
Copyright Holders © 2022 Ushio, Wada, Nakamura, Matsumoto, Hoshika, Shiromizu, Iwata, Esumi, Kajizono, Kitamura and Sendo.
File Version publisher
PubMed ID 36034871
DOI 10.3389/fphar.2022.890048
Web of Science KeyUT 000860773600001
Related Url isVersionOf https://doi.org/10.3389/fphar.2022.890048
JaLCDOI 10.18926/AMO/63410
FullText URL 76_2_167.pdf
Author Higashionna, Tsukasa| Ushio, Soichiro| Esumi, Satoru| Murakawa, Kiminaka| Kitamura, Yoshihisa| Sendo, Toshiaki|
Abstract Febrile neutropenia (FN) is a serious side effect in patients undergoing cancer chemotherapy and frequently proves fatal. Since infection control is crucial in the management of FN, the antimicrobial agent cefozopran (CZOP) has been recommended but not approved for routine use in clinical care of FN in Japan. However, few studies of CZOP in the management of FN have used a thrice daily dose schedule. The aim of this study was to retrospectively compare the efficacy and safety of CZOP at a dose of 1 g three times daily to those of cefepime (CFPM) in the treatment of FN in our lung cancer patients. The response rates of the CZOP and CFPM groups were 89.5% (17/19 cases) and 83.0% (39/47 cases), respectively, with no significant difference between the two groups. The median duration of antimicrobial treatment was 6 days (4-10 days) in the CZOP group and 7 days (3-13 days) in the CFPM group, with no significant difference between groups. The incidence rates of adverse events were 21.1% (4/19 cases) in the CZOP group and 19.1% (9/47 cases) in the CFPM group. No adverse events of Grade 3 or higher were observed in either group. The findings of the present study suggest that CZOP administration at a dose of 1 g three times per day as an antimicrobial treatment alternative against FN.
Keywords febrile neutropenia cefozopran cefepime lung cancer retrospective
Amo Type Original Article
Publication Title Acta Medica Okayama
Published Date 2022-04
Volume volume76
Issue issue2
Publisher Okayama University Medical School
Start Page 167
End Page 172
ISSN 0386-300X
NCID AA00508441
Content Type Journal Article
language English
Copyright Holders Copyright Ⓒ 2022 by Okayama University Medical School
File Version publisher
Refereed True
PubMed ID 35503444
Web of Science KeyUT 000792374900008
JaLCDOI 10.18926/AMO/61215
FullText URL 74_6_545.pdf
Author Tatebe, Yasuhisa| Kanamitsu, Kiichiro| Kanzaki, Hirotaka| Ishida, Hisashi| Fujiwara, Kaori| Washio, Kana| Kitamura, Yoshihisa| Sendo, Toshiaki| Shimada, Akira| Tsukahara, Hirokazu|
Abstract Polymorphisms in methotrexate transporter pathways have been associated with methotrexate toxicities and clearance. Recent genome-wide association studies have revealed that the SLCO1B1 T521C variant is associated with methotrexate elimination. We present a case of a pediatric patient with acute lymphoblastic leukemia who suffered from persistently high plasma methotrexate concentrations and acute kidney injuries after the admin-istration of a medium dose of methotrexate. Subsequent genetic analysis showed that he was a carrier of dys-functional genetic variants associated with methotrexate clearance. This case highlights that polymorphisms of methotrexate transporter pathways can adversely affect methotrexate elimination in a clinically significant manner.
Keywords methotrexate polymorphism drug elimination acute kidney injury acute lymphoblastic leukemia
Amo Type Case Report
Publication Title Acta Medica Okayama
Published Date 2020-12
Volume volume74
Issue issue6
Publisher Okayama University Medical School
Start Page 545
End Page 550
ISSN 0386-300X
NCID AA00508441
Content Type Journal Article
language English
Copyright Holders CopyrightⒸ 2020 by Okayama University Medical School
File Version publisher
Refereed True
PubMed ID 33361876
Web of Science KeyUT 000601203600012
NAID 120006948942
FullText URL fulltext.pdf
Author Kikuoka, Ryo| Miyazaki, Ikuko| Kubota, Natsuki| Maeda, Megumi| Kagawa, Daiki| Moriyama, Masaaki| Sato, Asuka| Murakami, Shinki| Kitamura, Yoshihisa| Sendo, Toshiaki| Asanuma, Masato|
Published Date 2020-11-26
Publication Title Scientific Reports
Volume volume10
Issue issue1
Publisher Nature Research
Start Page 20698
ISSN 2045-2322
Content Type Journal Article
language English
OAI-PMH Set 岡山大学
Copyright Holders © The Author(s) 2020
File Version publisher
PubMed ID 33244123
DOI 10.1038/s41598-020-77652-4
Web of Science KeyUT 000596329600054
Related Url isVersionOf https://doi.org/10.1038/s41598-020-77652-4
JaLCDOI 10.18926/AMO/60368
FullText URL 74_4_301.pdf
Author Takahashi, Kei| Kitamura, Yoshihisa| Ushio, Soichiro| Sendo, Toshiaki|
Abstract Ketamine has been clinically proven to ameliorate depression, including treatment-resistant depression. The detailed mechanism of action of ketamine in treatment-resistant depression remains unclear. We examined the effects of ketamine on the immobility times of adrenocorticotropic hormone (ACTH)-treated rats during the forced swim test, and we explored the mechanism by which ketamine acts in this model. We investigated the neuroanatomical site of action by microinjecting ketamine into the medial prefrontal cortex of rats. A significant reduction of the rats’ immobility during the forced swim test was observed after the intraperitoneal injection of ketamine in both saline- and ACTH-treated rats. The microinjection of ketamine into the medial prefrontal cortex also decreased immobility during the forced swim test in both saline- and ACTH-treated rats. The immobility-decreasing effect of intraperitoneally injected ketamine was blocked by administering WAY100635, a 5-HT1A receptor antagonist, into the medial prefrontal cortex. These findings contribute to the evidence that ketamine can be useful against treatment-resistant depressive conditions. The immobility-reducing effects of ketamine might be mediated by 5-HT1A receptor activity in the medial prefrontal cortex.
Keywords ketamine adrenocorticotropic hormone forced swim test medial prefrontal cortex 5-HT1A receptor
Amo Type Original Article
Publication Title Acta Medica Okayama
Published Date 2020-08
Volume volume74
Issue issue4
Publisher Okayama University Medical School
Start Page 301
End Page 306
ISSN 0386-300X
NCID AA00508441
Content Type Journal Article
language English
Copyright Holders CopyrightⒸ 2020 by Okayama University Medical School
File Version publisher
Refereed True
PubMed ID 32843761
Web of Science KeyUT 000562508700005
NAID 120006880207
FullText URL fulltext.pdf
Author Masaoka, Yasuyuki| Kawasaki, Yoichi| Kikuoka, Ryo| Ogawa, Atsushi| Esumi, Satoru| Wada, Yudai| Ushio, Soichiro| Kitamura, Yoshihisa| Sendo, Toshiaki|
Keywords Valganciclovir Simple suspension method Stability HPLC Gavage tube
Published Date 2020-07-07
Publication Title Journal of Pharmaceutical Health Care and Sciences
Volume volume6
Issue issue1
Publisher BMC
Start Page 16
ISSN 2055-0294
Content Type Journal Article
language English
OAI-PMH Set 岡山大学
Copyright Holders © The Author(s). 2020
File Version publisher
PubMed ID 32655872
DOI 10.1186/s40780-020-00172-w
Web of Science KeyUT 000549139200001
Related Url isVersionOf https://doi.org/10.1186/s40780-020-00172-w
Title Alternative Drug interaction (47. Combination with general anesthetics)
FullText URL 132_29.pdf
Author Igawa, Yusuke| Esumi, Satoru| Kitamura, Yoshihisa| Sendo, Toshiaki|
Publication Title Journal of Okayama Medical Association
Published Date 2020-04-01
Volume volume132
Issue issue1
Start Page 29
End Page 33
ISSN 0030-1558
Related Url isVersionOf https://doi.org/10.4044/joma.132.29
language Japanese
Copyright Holders Copyright (c) 2020 岡山医学会
File Version publisher
DOI 10.4044/joma.132.29
NAID 130007840319
FullText URL fulltext.pdf
Author Isooka, Nami| Miyazaki, Ikuko| Kikuoka, Ryo| Wada, Kouichi| Nakayama, Erika| Shin, Kotaro| Yamamoto, Daichi| Kitamura, Yoshihisa| Asanuma, Masato|
Keywords Astrocyte Dopamine agonist Metallothionein Parkinson's disease Rotigotine Serotonin 1A receptor
Published Date 2020-01-31
Publication Title Neurochemistry International
Volume volume132
Publisher Elsevier
Start Page 104608
ISSN 01970186
NCID AA0032399X
Content Type Journal Article
language English
OAI-PMH Set 岡山大学
Copyright Holders © 2019 The Authors. Published by Elsevier Ltd.
File Version publisher
PubMed ID 31765686
DOI 10.1016/j.neuint.2019.104608
Web of Science KeyUT 000508747200014
Related Url isVersionOf https://doi.org/10.1016/j.neuint.2019.104608
FullText URL fulltext.pdf
Author Koyama, Toshihiro| Sasaki, Misato| Hagiya, Hideharu| Zamami, Yoshito| Funahashi, Tomoko| Ohshima, Ayako| Tatebe, Yasuhisa| Mikami, Naoko| Shinomiya, Kazuaki| Kitamura, Yoshihisa| Sendo, Toshiaki| Hinotsu, Shiro| Kano, Mitsunobu R.|
Published Date 2019-12-27
Publication Title Scientific Reports
Volume volume9
Publisher Nature Publishing Group
Start Page 20235
ISSN 2045-2322
Content Type Journal Article
language English
OAI-PMH Set 岡山大学
Copyright Holders © The Author(s) 2019
File Version publisher
PubMed ID 31882673
DOI 10.1038/s41598-019-56388-w
Web of Science KeyUT 000509351200002
Related Url isVersionOf https://doi.org/10.1038/s41598-019-56388-w
FullText URL fulltext.pdf
Author Takeda, Tatsuaki| Yamamoto, Hiromasa| Suzawa, Ken| Tomida, Shuta| Miyauchi, Shunsaku| Araki, Kota| Nakata, Kentaro| Miura, Akihiro| Namba, Kei| Shien, Kazuhiko| Soh, Junichi| Shien, Tadahiko| Kitamura, Yoshihisa| Sendo, Toshiaki| Toyooka, Shinichi|
Keywords breast cancer drug resistance lung cancer neratinib YES1
Published Date 2019-12-19
Publication Title Cancer Science
Volume volume111
Issue issue3
Publisher Wiley
Start Page 849
End Page 856
ISSN 1347-9032
Content Type Journal Article
language English
OAI-PMH Set 岡山大学
Copyright Holders © 2019 The Authors.
File Version publisher
PubMed ID 31856375
DOI 10.1111/cas.14289
Web of Science KeyUT 000507433400001
Related Url isVersionOf https://doi.org/10.1111/cas.14289
FullText URL fulltext.pdf
Author Hagiya, Hideharu| Koyama, Toshihiro| Zamami, Yoshito| Tatebe, Yasuhisa| Funahashi, Tomoko| Shinomiya, Kazuaki| Kitamura, Yoshihisa| Hinotsu, Shiro| Sendo, Toshiaki| Rakugi, Hiromi| Kano, Mitsunobu R.|
Keywords adult intensive & critical care epidemiology geriatric medicine health & safety health policy public health
Published Date 2019-12-11
Publication Title BMJ OPEN
Volume volume9
Issue issue12
Publisher BMJ Publishing Group
Start Page e033462
ISSN 2044-6055
Content Type Journal Article
language English
OAI-PMH Set 岡山大学
Copyright Holders © Author(s) (or theiremployer(s)) 2019.
File Version publisher
PubMed ID 31831549
DOI 10.1136/bmjopen-2019-033462
Web of Science KeyUT 000512773400250
Related Url isVersionOf https://doi.org/10.1136/bmjopen-2019-033462
Title Alternative Drug interaction(46. Blending change and interaction of an injection drug)
FullText URL 131_161.pdf
Author Morishita, Yosuke| Esumi, Satoru| Nishihara, Shigeki| Kitamura, Yoshihisa| Sendo, Toshiaki|
Publication Title Journal of Okayama Medical Association
Published Date 2019-12-02
Volume volume131
Issue issue3
Start Page 161
End Page 164
ISSN 0030-1558
Related Url isVersionOf https://doi.org/10.4044/joma.131.161
language Japanese
Copyright Holders Copyright (c) 2019 岡山医学会
File Version publisher
DOI 10.4044/joma.131.161
NAID 130007782628
FullText URL fulltext.pdf
Author Asanuma, Masato| Okumura-Torigoe, Nao| Miyazaki, Ikuko| Murakami, Shinki| Kitamura, Yoshihisa| Sendo, Toshiaki|
Keywords astrocyte neuroprotection region-specificity striatum mesencephalon oxidative stress 6-hydroxydopamine Nrf2 phase II detoxifying molecules
Published Date 2019-01-30
Publication Title International Journal of Molecular Sciences
Volume volume20
Issue issue3
Publisher MDPI
Start Page 598
ISSN 1422-0067
NCID AA12038549
Content Type Journal Article
language English
OAI-PMH Set 岡山大学
File Version publisher
PubMed ID 30704073
DOI 10.3390/ijms20030598
Web of Science KeyUT 000462412500142
Related Url isVersionOf https://doi.org/10.3390/ijms20030598
Title Alternative Drug interaction (39. Drug interaction in prostate cancer therapy)
FullText URL 129_131.pdf
Author Kanzaki, Hirotaka| Tanaka, Yuta| Maruo, Akinori| Nishihara, Shigeki | Kitamura, Yoshihisa| Sendo, Toshiaki|
Publication Title Journal of Okayama Medical Association
Published Date 2017-08-01
Volume volume129
Issue issue2
Start Page 131
End Page 136
ISSN 0030-1558
Related Url https://doi.org/10.4044/joma.129.131
language Japanese
Copyright Holders Copyright (c) 2017 岡山医学会
File Version publisher
DOI 10.4044/joma.129.131
NAID 130006039378
Title Alternative Drug interaction (38. Combination with novel hypnotic drugs : ramelteon and suvorexant)
FullText URL 129_53.pdf
Author Kubo, Kazuko| Esumi, Satoru| Kitamura, Yoshihisa| Sendo, Toshiaki|
Publication Title Journal of Okayama Medical Association
Published Date 2017-04-03
Volume volume129
Issue issue1
Start Page 53
End Page 57
ISSN 0030-1558
language Japanese
Copyright Holders Copyright (c) 2017 岡山医学会
File Version publisher
DOI 10.4044/joma.129.53
NAID 130005632075
Author Miyamoto, Masashi| Esumi, Satoru| Kitamura, Yoshihisa| Sendo, Toshiaki|
Published Date 2016-12-01
Publication Title Journal of Okayama Medical Association
Volume volume128
Issue issue3
Content Type Article
Title Alternative Drug interaction (36. Combination with oral molecular target drugs in lung cancer)
FullText URL 128_141.pdf
Author Higashionna, Tsukasa| Esumi, Satoru| Kitamura, Yoshihisa| Sendo, Toshiaki|
Publication Title Journal of Okayama Medical Association
Published Date 2016-08-01
Volume volume128
Issue issue2
Start Page 141
End Page 146
ISSN 0030-1558
Related Url isVersionOf https://doi.org/10.4044/joma.128.141
language Japanese
Copyright Holders Copyright (c) 2016 岡山医学会
File Version publisher
DOI 10.4044/joma.128.141
NAID 130005262644
Title Alternative Drug interaction (35. Opioid-analgesic drug interactions)
FullText URL 128_53.pdf
Author Sada, Hikaru| Kajizono, Makoto| Kitamura, Yoshihisa| Sendo, Toshiaki|
Publication Title 岡山医学会雑誌
Published Date 2016-04-01
Volume volume128
Issue issue1
Start Page 53
End Page 59
ISSN 0030-1558
Related Url isVersionOf https://doi.org/10.4044/joma.128.53
language Japanese
Copyright Holders Copyright (c) 2016 岡山医学会
File Version publisher
DOI 10.4044/joma.128.53
NAID 130005149610
Title Alternative Drug interaction (34. Drug interactions of food and medicine)
FullText URL 127_245.pdf
Author Hino, Hayato| Kitamura, Yoshihisa| Sendo, Toshiaki|
Publication Title 岡山医学会雑誌
Published Date 2015-12-01
Volume volume127
Issue issue3
Start Page 245
End Page 249
ISSN 0030-1558
Related Url isVersionOf https://doi.org/10.4044/joma.127.245
language Japanese
Copyright Holders Copyright (c) 2015 岡山医学会
File Version publisher
DOI 10.4044/joma.127.245
NAID 130005116813
FullText URL K0005463_other1.pdf
Author Higuchi, Yuji | Uchitomi, Yosuke| Fujimori, Maiko| Koyama, Toshihiro| Kataoka, Hitomi| Kitamura, Yoshihisa| Sendo, Toshiaki| Inagaki, Masatoshi|
Keywords Empathy Hospital pharmacist Japan Pharmaceutical care
Note The final publication is available at Springer| 岡山大学審査学位副論文|
Published Date 2015-12
Publication Title International Journal of Clinical Pharmacy
Volume volume37
Issue issue6
Publisher Springer
Start Page 1258
End Page 1266
ISSN 2210-7703
NCID AA12633112
Content Type Journal Article
language English
OAI-PMH Set 岡山大学
Copyright Holders https://creativecommons.org/licenses/by-nc-nd/4.0/deed.ja
File Version author
PubMed ID 26441314
DOI 10.1007/s11096-015-0204-2
Web of Science KeyUT 000363490100042
Related Url https://doi.org/10.1007/s11096-015-0204-2 http://ousar.lib.okayama-u.ac.jp/55016